Boehringer Ingelheim Pharmaceuticals, Inc., the US subsidiary of Boehringer Ingelheim, headquartered in Germany, operates globally with more than 44,000 employees. The company is committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.
Visit http://us.boehringer-ingelheim.com, Follow us on twitter at @boehringerus.
Product Categories
- Pharmaceuticals